Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- WORLD NEWS IN BRIEF
May 13, 2002
- President-elect Kobori to Follow Handa's Policy: MPC
May 13, 2002
- DIAGNOSTIC NEWS IN BRIEF
May 13, 2002
- SSP, Kirin Screen New LMW Compounds for Drug Discovery
May 13, 2002
- MEDICAL DEVICE NEWS IN BRIEF
May 13, 2002
- Sumitomo Agrees with GSK on Naratripan
May 13, 2002
- The South Africa Clinical Trial Mission
May 13, 2002
- Takeda Restructures Intellectual Property Department
May 13, 2002
- BULLETIN
May 13, 2002
- Eisai to Apply for Vascular Dementia for Aricept in US
April 29, 2002
- REGULATORY NEWS IN BRIEF
April 29, 2002
- Mr Nordhoff Talks about Prospects of Gen-Probe
April 29, 2002
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
April 29, 2002
- PhRMA Japan Representative Discusses AIDS in Developing Countries
April 29, 2002
- BI to Introduce Int'l Strategic Products into Japan
April 29, 2002
- Aventis, Fujisawa Form Alliance for Marketing of Synercid Injection
April 29, 2002
- Korosho to Beef Up Measures to Ensure Medical Safety
April 29, 2002
- SSP Licenses Spelear to Han All Pharm in South Korea
April 29, 2002
- Medical Facilities Run by Profit-making Firms to Be Discussed Again
April 29, 2002
- Vital-Net, Ohmori Yakuhin Tohoku to Merge in July
April 29, 2002
ページ
Japan is ramping up its push to spread regional formularies nationwide, a policy expected to standardize treatments, strengthen supply resilience,…
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…